Covid-19 Impact on Neurovascular Stent Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Neurovascular Stent, including the following market information:
Major competitors identified in this market include Abbott Laboratories (USA), Gore Medical (USA), Terumo Medical (Japan), Johnson & Johnson (USA), Medtronic (USA), Acandis (Germany), Stryker (USA), MicroPort Scientific (China), Cordis (USA), etc.
Based on the Region:
- Global Neurovascular Stent Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Neurovascular Stent Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Neurovascular Stent Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Neurovascular Stent Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Abbott Laboratories (USA), Gore Medical (USA), Terumo Medical (Japan), Johnson & Johnson (USA), Medtronic (USA), Acandis (Germany), Stryker (USA), MicroPort Scientific (China), Cordis (USA), etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Carotid artery stents
- Intracranial stents
- Hospitals
- Ambulatory Surgical Centers
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neurovascular Stent Industry
1.7 COVID-19 Impact: Neurovascular Stent Market Trends
2 GLOBAL NEUROVASCULAR STENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Neurovascular Stent Business Impact Assessment - COVID-19
2.1.1 Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Neurovascular Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neurovascular Stent Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Neurovascular Stent Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Neurovascular Stent Factory Price by Manufacturers
3.3 Location of Key Manufacturers Neurovascular Stent Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Neurovascular Stent Market
3.5 Key Manufacturers Neurovascular Stent Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NEUROVASCULAR STENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Carotid artery stents
1.4.2 Intracranial stents
4.2 By Type, Global Neurovascular Stent Market Size, 2019-2021
4.2.1 By Type, Global Neurovascular Stent Market Size by Type, 2020-2021
4.2.2 By Type, Global Neurovascular Stent Price, 2020-2021
5 IMPACT OF COVID-19 ON NEUROVASCULAR STENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Ambulatory Surgical Centers
5.5.3 Others
5.2 By Application, Global Neurovascular Stent Market Size, 2019-2021
5.2.1 By Application, Global Neurovascular Stent Market Size by Application, 2019-2021
5.2.2 By Application, Global Neurovascular Stent Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories (USA)
7.1.1 Abbott Laboratories (USA) Business Overview
7.1.2 Abbott Laboratories (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.1.3 Abbott Laboratories (USA) Neurovascular Stent Product Introduction
7.1.4 Abbott Laboratories (USA) Response to COVID-19 and Related Developments
7.2 Gore Medical (USA)
7.2.1 Gore Medical (USA) Business Overview
7.2.2 Gore Medical (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.2.3 Gore Medical (USA) Neurovascular Stent Product Introduction
7.2.4 Gore Medical (USA) Response to COVID-19 and Related Developments
7.3 Terumo Medical (Japan)
7.3.1 Terumo Medical (Japan) Business Overview
7.3.2 Terumo Medical (Japan) Neurovascular Stent Quarterly Production and Revenue, 2020
7.3.3 Terumo Medical (Japan) Neurovascular Stent Product Introduction
7.3.4 Terumo Medical (Japan) Response to COVID-19 and Related Developments
7.4 Johnson & Johnson (USA)
7.4.1 Johnson & Johnson (USA) Business Overview
7.4.2 Johnson & Johnson (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson (USA) Neurovascular Stent Product Introduction
7.4.4 Johnson & Johnson (USA) Response to COVID-19 and Related Developments
7.5 Medtronic (USA)
7.5.1 Medtronic (USA) Business Overview
7.5.2 Medtronic (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.5.3 Medtronic (USA) Neurovascular Stent Product Introduction
7.5.4 Medtronic (USA) Response to COVID-19 and Related Developments
7.6 Acandis (Germany)
7.6.1 Acandis (Germany) Business Overview
7.6.2 Acandis (Germany) Neurovascular Stent Quarterly Production and Revenue, 2020
7.6.3 Acandis (Germany) Neurovascular Stent Product Introduction
7.6.4 Acandis (Germany) Response to COVID-19 and Related Developments
7.7 Stryker (USA)
7.7.1 Stryker (USA) Business Overview
7.7.2 Stryker (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.7.3 Stryker (USA) Neurovascular Stent Product Introduction
7.7.4 Stryker (USA) Response to COVID-19 and Related Developments
7.8 MicroPort Scientific (China)
7.8.1 MicroPort Scientific (China) Business Overview
7.8.2 MicroPort Scientific (China) Neurovascular Stent Quarterly Production and Revenue, 2020
7.8.3 MicroPort Scientific (China) Neurovascular Stent Product Introduction
7.8.4 MicroPort Scientific (China) Response to COVID-19 and Related Developments
7.9 Cordis (USA)
7.9.1 Cordis (USA) Business Overview
7.9.2 Cordis (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.9.3 Cordis (USA) Neurovascular Stent Product Introduction
7.9.4 Cordis (USA) Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Neurovascular Stent Supply Chain Analysis
8.1.1 Neurovascular Stent Supply Chain Analysis
8.1.2 Covid-19 Impact on Neurovascular Stent Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Neurovascular Stent Distribution Channels
8.2.2 Covid-19 Impact on Neurovascular Stent Distribution Channels
8.2.3 Neurovascular Stent Distributors
8.3 Neurovascular Stent Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neurovascular Stent Industry
1.7 COVID-19 Impact: Neurovascular Stent Market Trends
2 GLOBAL NEUROVASCULAR STENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Neurovascular Stent Business Impact Assessment - COVID-19
2.1.1 Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Neurovascular Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neurovascular Stent Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Neurovascular Stent Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Neurovascular Stent Factory Price by Manufacturers
3.3 Location of Key Manufacturers Neurovascular Stent Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Neurovascular Stent Market
3.5 Key Manufacturers Neurovascular Stent Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NEUROVASCULAR STENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Carotid artery stents
1.4.2 Intracranial stents
4.2 By Type, Global Neurovascular Stent Market Size, 2019-2021
4.2.1 By Type, Global Neurovascular Stent Market Size by Type, 2020-2021
4.2.2 By Type, Global Neurovascular Stent Price, 2020-2021
5 IMPACT OF COVID-19 ON NEUROVASCULAR STENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Ambulatory Surgical Centers
5.5.3 Others
5.2 By Application, Global Neurovascular Stent Market Size, 2019-2021
5.2.1 By Application, Global Neurovascular Stent Market Size by Application, 2019-2021
5.2.2 By Application, Global Neurovascular Stent Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories (USA)
7.1.1 Abbott Laboratories (USA) Business Overview
7.1.2 Abbott Laboratories (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.1.3 Abbott Laboratories (USA) Neurovascular Stent Product Introduction
7.1.4 Abbott Laboratories (USA) Response to COVID-19 and Related Developments
7.2 Gore Medical (USA)
7.2.1 Gore Medical (USA) Business Overview
7.2.2 Gore Medical (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.2.3 Gore Medical (USA) Neurovascular Stent Product Introduction
7.2.4 Gore Medical (USA) Response to COVID-19 and Related Developments
7.3 Terumo Medical (Japan)
7.3.1 Terumo Medical (Japan) Business Overview
7.3.2 Terumo Medical (Japan) Neurovascular Stent Quarterly Production and Revenue, 2020
7.3.3 Terumo Medical (Japan) Neurovascular Stent Product Introduction
7.3.4 Terumo Medical (Japan) Response to COVID-19 and Related Developments
7.4 Johnson & Johnson (USA)
7.4.1 Johnson & Johnson (USA) Business Overview
7.4.2 Johnson & Johnson (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson (USA) Neurovascular Stent Product Introduction
7.4.4 Johnson & Johnson (USA) Response to COVID-19 and Related Developments
7.5 Medtronic (USA)
7.5.1 Medtronic (USA) Business Overview
7.5.2 Medtronic (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.5.3 Medtronic (USA) Neurovascular Stent Product Introduction
7.5.4 Medtronic (USA) Response to COVID-19 and Related Developments
7.6 Acandis (Germany)
7.6.1 Acandis (Germany) Business Overview
7.6.2 Acandis (Germany) Neurovascular Stent Quarterly Production and Revenue, 2020
7.6.3 Acandis (Germany) Neurovascular Stent Product Introduction
7.6.4 Acandis (Germany) Response to COVID-19 and Related Developments
7.7 Stryker (USA)
7.7.1 Stryker (USA) Business Overview
7.7.2 Stryker (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.7.3 Stryker (USA) Neurovascular Stent Product Introduction
7.7.4 Stryker (USA) Response to COVID-19 and Related Developments
7.8 MicroPort Scientific (China)
7.8.1 MicroPort Scientific (China) Business Overview
7.8.2 MicroPort Scientific (China) Neurovascular Stent Quarterly Production and Revenue, 2020
7.8.3 MicroPort Scientific (China) Neurovascular Stent Product Introduction
7.8.4 MicroPort Scientific (China) Response to COVID-19 and Related Developments
7.9 Cordis (USA)
7.9.1 Cordis (USA) Business Overview
7.9.2 Cordis (USA) Neurovascular Stent Quarterly Production and Revenue, 2020
7.9.3 Cordis (USA) Neurovascular Stent Product Introduction
7.9.4 Cordis (USA) Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Neurovascular Stent Supply Chain Analysis
8.1.1 Neurovascular Stent Supply Chain Analysis
8.1.2 Covid-19 Impact on Neurovascular Stent Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Neurovascular Stent Distribution Channels
8.2.2 Covid-19 Impact on Neurovascular Stent Distribution Channels
8.2.3 Neurovascular Stent Distributors
8.3 Neurovascular Stent Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neurovascular Stent Assessment
Table 9. COVID-19 Impact: Neurovascular Stent Market Trends
Table 10. COVID-19 Impact Global Neurovascular Stent Market Size
Table 11. Global Neurovascular Stent Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Neurovascular Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Neurovascular Stent Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Neurovascular Stent Market Growth Drivers
Table 17. Global Neurovascular Stent Market Restraints
Table 18. Global Neurovascular Stent Market Opportunities
Table 19. Global Neurovascular Stent Market Challenges
Table 20. Key Manufacturers Neurovascular Stent Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Neurovascular Stent Market Size, 2019 (K Units) & (US$ Million)
Table 22. Neurovascular Stent Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Neurovascular Stent Manufacturing Plants
Table 24. Key Manufacturers Neurovascular Stent Market Served
Table 25. Date of Key Manufacturers Enter into Neurovascular Stent Market
Table 26. Key Manufacturers Neurovascular Stent Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurovascular Stent Market Size by Type, 2020, (US$ Million)
Table 29. Global Neurovascular Stent Market Size by Type, 2020 (K Units)
Table 30. Global Neurovascular Stent Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Neurovascular Stent Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Neurovascular Stent Market Size by Application, 2020-2021 (K Units)
Table 33. Global Neurovascular Stent Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Neurovascular Stent Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Neurovascular Stent Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 38. US Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 43. Germany Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 50. China Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Laboratories (USA) Business Overview
Table 58. Abbott Laboratories (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories (USA) Neurovascular Stent Product
Table 60. Abbott Laboratories (USA) Response to COVID-19 and Related Developments
Table 61. Gore Medical (USA) Business Overview
Table 62. Gore Medical (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Gore Medical (USA) Neurovascular Stent Product
Table 64. Gore Medical (USA) Response to COVID-19 and Related Developments
Table 65. Terumo Medical (Japan) Business Overview
Table 66. Terumo Medical (Japan) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Terumo Medical (Japan) Neurovascular Stent Product
Table 68. Terumo Medical (Japan) Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson (USA) Business Overview
Table 70. Johnson & Johnson (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson (USA) Neurovascular Stent Product
Table 72. Johnson & Johnson (USA) Response to COVID-19 and Related Developments
Table 73. Medtronic (USA) Business Overview
Table 74. Medtronic (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Medtronic (USA) Neurovascular Stent Product
Table 76. Medtronic (USA) Response to COVID-19 and Related Developments
Table 77. Acandis (Germany) Business Overview
Table 78. Acandis (Germany) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Acandis (Germany) Neurovascular Stent Product
Table 80. Acandis (Germany) Response to COVID-19 and Related Developments
Table 81. Stryker (USA) Business Overview
Table 82. Stryker (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Stryker (USA) Neurovascular Stent Product
Table 84. Stryker (USA) Response to COVID-19 and Related Developments
Table 85. MicroPort Scientific (China) Business Overview
Table 86. MicroPort Scientific (China) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. MicroPort Scientific (China) Neurovascular Stent Product
Table 88. MicroPort Scientific (China) Response to COVID-19 and Related Developments
Table 89. Cordis (USA) Business Overview
Table 90. Cordis (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cordis (USA) Neurovascular Stent Product
Table 92. Cordis (USA) Response to COVID-19 and Related Developments
Table 93. Neurovascular Stent Distributors List
Table 94. Neurovascular Stent Customers List
Table 95. Covid-19 Impact on Neurovascular Stent Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neurovascular Stent Assessment
Table 9. COVID-19 Impact: Neurovascular Stent Market Trends
Table 10. COVID-19 Impact Global Neurovascular Stent Market Size
Table 11. Global Neurovascular Stent Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Neurovascular Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Neurovascular Stent Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Neurovascular Stent Market Growth Drivers
Table 17. Global Neurovascular Stent Market Restraints
Table 18. Global Neurovascular Stent Market Opportunities
Table 19. Global Neurovascular Stent Market Challenges
Table 20. Key Manufacturers Neurovascular Stent Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Neurovascular Stent Market Size, 2019 (K Units) & (US$ Million)
Table 22. Neurovascular Stent Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Neurovascular Stent Manufacturing Plants
Table 24. Key Manufacturers Neurovascular Stent Market Served
Table 25. Date of Key Manufacturers Enter into Neurovascular Stent Market
Table 26. Key Manufacturers Neurovascular Stent Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurovascular Stent Market Size by Type, 2020, (US$ Million)
Table 29. Global Neurovascular Stent Market Size by Type, 2020 (K Units)
Table 30. Global Neurovascular Stent Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Neurovascular Stent Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Neurovascular Stent Market Size by Application, 2020-2021 (K Units)
Table 33. Global Neurovascular Stent Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Neurovascular Stent Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Neurovascular Stent Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 38. US Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 43. Germany Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Neurovascular Stent Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Neurovascular Stent Market Size, 2019-2021 (K Units)
Table 50. China Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Neurovascular Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Laboratories (USA) Business Overview
Table 58. Abbott Laboratories (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories (USA) Neurovascular Stent Product
Table 60. Abbott Laboratories (USA) Response to COVID-19 and Related Developments
Table 61. Gore Medical (USA) Business Overview
Table 62. Gore Medical (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Gore Medical (USA) Neurovascular Stent Product
Table 64. Gore Medical (USA) Response to COVID-19 and Related Developments
Table 65. Terumo Medical (Japan) Business Overview
Table 66. Terumo Medical (Japan) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Terumo Medical (Japan) Neurovascular Stent Product
Table 68. Terumo Medical (Japan) Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson (USA) Business Overview
Table 70. Johnson & Johnson (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson (USA) Neurovascular Stent Product
Table 72. Johnson & Johnson (USA) Response to COVID-19 and Related Developments
Table 73. Medtronic (USA) Business Overview
Table 74. Medtronic (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Medtronic (USA) Neurovascular Stent Product
Table 76. Medtronic (USA) Response to COVID-19 and Related Developments
Table 77. Acandis (Germany) Business Overview
Table 78. Acandis (Germany) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Acandis (Germany) Neurovascular Stent Product
Table 80. Acandis (Germany) Response to COVID-19 and Related Developments
Table 81. Stryker (USA) Business Overview
Table 82. Stryker (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Stryker (USA) Neurovascular Stent Product
Table 84. Stryker (USA) Response to COVID-19 and Related Developments
Table 85. MicroPort Scientific (China) Business Overview
Table 86. MicroPort Scientific (China) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. MicroPort Scientific (China) Neurovascular Stent Product
Table 88. MicroPort Scientific (China) Response to COVID-19 and Related Developments
Table 89. Cordis (USA) Business Overview
Table 90. Cordis (USA) Neurovascular Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cordis (USA) Neurovascular Stent Product
Table 92. Cordis (USA) Response to COVID-19 and Related Developments
Table 93. Neurovascular Stent Distributors List
Table 94. Neurovascular Stent Customers List
Table 95. Covid-19 Impact on Neurovascular Stent Customers
LIST OF FIGURES
Figure 1. Neurovascular Stent Product Picture
Figure 2. Neurovascular Stent Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neurovascular Stent Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neurovascular Stent Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neurovascular Stent Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neurovascular Stent Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neurovascular Stent Market Size Market Share, 2019-2021
Figure 1. Neurovascular Stent Product Picture
Figure 2. Neurovascular Stent Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neurovascular Stent Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neurovascular Stent Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neurovascular Stent Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neurovascular Stent Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neurovascular Stent Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neurovascular Stent Market Size Market Share, 2019-2021
